-+ 0.00%
-+ 0.00%
-+ 0.00%

CIPROCOPAN (NXP100) RECEIVES MARKETING APPROVAL IN CHINA FOR THE TREATMENT OF PATIENTS WITH PNH PREVIOUSLY UNTREATED WITH COMPLEMENT INHIBITORS

Reuters·07/23/2026 11:30:00

Please log in to view news